Real-World Glycemic Outcomes of Open-Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups.
AIMS To assess glycemic outcomes across different age groups and explore factors associated with glycemic target achievement during 12-months open-source android artificial pancreas (AAPS) use among people with type 1 diabetes (T1D). METHODS This study included people with T1D who had used AAPS continuously for 12 mo...